Related Experiment Videos
Soft tissue sarcomas: current trends in diagnosis and management
K H Antman1, F R Eilber, M H Shiu
1Division of Medicine, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Current Problems in Cancer
|November 1, 1989
Summary
Sarcomas are rare, diverse tumors originating from connective tissues. This review covers pathology, surgery, and therapies for bone and soft tissue sarcomas, aiming to guide optimal treatment strategies.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Sarcomas, fleshy tumors, have distinct origins from carcinomas.
- They share embryological links with leukemias and lymphomas, arising from mesodermal tissue, with neurosarcomas being an exception.
- Malignant soft tissue sarcomas are rare, diverse tumors with varied histology, behavior, and origin.
Purpose of the Study:
- To review current concepts in the pathology of sarcomas.
- To discuss advancements in surgical, radiation, and chemotherapeutic treatments.
- To explore multimodality therapy approaches for sarcomas.
Main Methods:
- Review of recent literature on sarcoma pathology.
- Analysis of current treatment modalities including surgery, radiation therapy, and chemotherapy.
- Synthesis of information on multimodality treatment strategies.
Main Results:
- Sarcoma incidence varies by histologic type and age group (e.g., rhabdomyosarcoma, osteosarcoma, Ewing's sarcoma).
- Specific sarcoma types show demographic variations (e.g., Ewing's sarcoma in Caucasians).
- The rarity and diversity of sarcomas complicate direct treatment comparisons.
Conclusions:
- Optimal primary therapy for sarcomas remains challenging due to tumor heterogeneity.
- A comprehensive review of pathology and therapeutic options is crucial.
- Further research and collaboration are needed to determine the best treatment protocols.